COVID-19 infection in a patient with multiple sclerosis treated with fingolimod

We present a patient with MS treated with fingolimod who was diagnosed with COVID-19 and had a favorable outcome.

Source: Neurology Neuroimmunology and Neuroinflammation - May 4, 2020 Category: Neurology Authors: Barzegar, M., Mirmosayyeb, O., Nehzat, N., Sarrafi, R., Khorvash, F., Maghzi, A.-H., Shaygannejad, V. Tags: COVID-19, Multiple sclerosis Clinical/Scientific Notes Source Type: research